NCR2 and neoplasm: • reduced NKG2D expression and signaling (82)• reduced NKp44 (83) signaling• decreased metabolism leading to lower IFN-γ, granzyme B and TRAIL expression (86)• higher tumor infiltration of low cytotoxic CD56bright NK cells (72, 73)